Fig. 3
From: Advances in radiotherapy and immunity in hepatocellular carcinoma
Combination treatments of radiotherapy and immunotherapy for HCC under investigation. Combination strategies reported or in ongoing investigations are presented, and lines demonstrate combinations of multiple immunotherapies. PD-1/L1 programmed cell death 1/ ligand 1; CTLA-4 cytotoxic T lymphocyte-associated antigen 4; TIM3 T-cell immunoglobulin and mucin-domain containing molecule 3; VEGF vascular endothelial growth factor